The Mutational Profiles of EGFR 19 Exon Deletion and 21 Exon L858R Mutation and Their Association with Primary Response to EGFR-TKIs

被引：0
|
作者：
Liang, W. [1 ,2 ,3 ]
Li, C. [1 ,2 ,3 ]
Zhao, Y. [2 ,4 ,5 ]
He, J. [2 ,4 ,5 ]
机构：
[1] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China
[2] China State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China
[3] Natl Clin Res Ctr Resp Dis, Guangzhou, Guangdong, Peoples R China
[4] Guangzhou Med Univ, Affiliated Hosp 1, Thorac Surg & Oncol, Guangzhou, Guangdong, Peoples R China
[5] Guangzhou Inst Resp Dis, Guangzhou, Guangdong, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
EGFR 19 Exon Deletion; EGFR 21 Exon L858R Mutation; Concomitant Mutations;
D O I：
10.1016/j.jtho.2018.08.442
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MA15.05
引用
收藏
页码：S408 / S408
页数：1
相关论文
共 50 条
  • [41] Equal efficacy of gefitinib in chemonaive lung adenocarcinoma patients with either exon 19 deletion or L858R point mutation
    Lin, Chou-Han
    Ho, Chao-Chi
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [42] Identification of non-small-cell lung cancer with activating EGFR mutations in malignant effusion and cerebrospinal fluid: Rapid and sensitive detection of exon 19 deletion E746-A750 and exon 21 L858R mutation by immunocytochemistry
    Kawahara, Akihiko
    Azuma, Koichi
    Sumi, Akiko
    Taira, Tomoki
    Nakashima, Kazutaka
    Aikawa, Emiko
    Abe, Hideyuki
    Yamaguchi, Tomohiko
    Takamori, Shinzo
    Akiba, Jun
    Kage, Masayoshi
    LUNG CANCER, 2011, 74 (01) : 35 - 40
  • [43] Association of EGFR L858R Mutation in Circulating Free DNA With Survival in the EURTAC Trial
    Karachaliou, Niki
    Mayo-de las Casas, Clara
    Queralt, Cristina
    de Aguirre, Itziar
    Melloni, Boris
    Cardenal, Felipe
    Garcia-Gomez, Ramon
    Massuti, Bartomeu
    Miguel Sanchez, Jose
    Porta, Ruth
    Ponce-Aix, Santiago
    Moran, Teresa
    Carcereny, Enric
    Felip, Enriqueta
    Bover, Isabel
    Insa, Amelia
    Reguart, Noemi
    Isla, Dolores
    Vergnenegre, Alain
    de Marinis, Filippo
    Gervais, Radj
    Corre, Romain
    Paz-Ares, Luis
    Morales-Espinosa, Daniela
    Viteri, Santiago
    Drozdowskyj, Ana
    Jordana-Ariza, Nuria
    Luis Ramirez-Serrano, Jose
    Angel Molina-Vila, Miguel
    Rosell, Rafael
    JAMA ONCOLOGY, 2015, 1 (02) : 149 - 157
  • [44] Comparing overall survival between first generation EGFR-TKIs and chemotherapy in lung cancer patients with Del19/L858R
    Wei Deng
    Yuanyuan Lei
    Siyang Liu
    Jinji Yang
    Haiyan Tu
    Honghong Yan
    Yilong Wu
    Chinese Journal of Cancer Research, 2016, 28 (03) : 339 - 347
  • [45] Comparing overall survival between first generation EGFR-TKIs and chemotherapy in lung cancer patients with Del19/L858R
    Deng, Wei
    Lei, Yuanyuan
    Liu, Siyang
    Yang, Jinji
    Tu, Haiyan
    Yan, Honghong
    Wu, Yilong
    CHINESE JOURNAL OF CANCER RESEARCH, 2016, 28 (03) : 339 - 347
  • [46] Patients with Exon 19 Deletion Were Associated with Longer Progression-Free Survival Compared to Those with L858R Mutation after First-Line EGFR-TKIs for Advanced Non-Small Cell Lung Cancer: A Meta-Analysis
    Zhang, Yaxiong
    Sheng, Jin
    Kang, Shiyang
    Fang, Wenfeng
    Yan, Yue
    Hu, Zhihuang
    Hong, Shaodong
    Wu, Xuan
    Qin, Tao
    Liang, Wenhua
    Zhang, Li
    PLOS ONE, 2014, 9 (09):
  • [47] Primary Drug Resistance to EGFR-TKIs by EGFR p.V1010M Germline Mutation Combined with EGFR p.L858R Somatic Mutation and its Pedigree Analysis
    Li, N.
    Liu, C.
    Xiong, L.
    Huang, D.
    Shen, X.
    Zhang, H.
    She, X.
    Jiang, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S634 - S634
  • [48] EGFR exon 21 L858R as an acquired resistance mechanism to nivolumab in a lung cancer patient originally driver gene-negative
    Xia, Chen
    Zeng, Fanxu
    Zhang, Yongchang
    THORACIC CANCER, 2019, 10 (05) : 1256 - 1259
  • [49] Low plasma concentration of gefitinib in patients with EGFR exon 21 L858R point mutations shortens progression-free survival
    Yuji Okuda
    Kazuhiro Sato
    Kazuhisa Sudo
    Yukiyasu Hasegawa
    Mariko Asano
    Hajime Miura
    Masahide Takeda
    Masaaki Sano
    Hiroyuki Watanabe
    Hiroyuki Kobayashi
    Takenori Niioka
    Masatomo Miura
    Hiroshi Ito
    Cancer Chemotherapy and Pharmacology, 2017, 79 : 1013 - 1020
  • [50] The Difference of Clinical Characteristics Between Patients With Exon 19 Deletion and Those With L858R Mutation in Nonsmall Cell Lung Cancer
    Zhang, Yaxiong
    He, Dacheng
    Fang, Wenfeng
    Kang, Shiyang
    Chen, Gang
    Hong, Shaodong
    Sheng, Jin
    Zhan, Jianhua
    Chen, Nan
    Hu, Zhihuang
    Xue, Cong
    Yang, Yunpeng
    Ma, Yuxiang
    Qin, Tao
    Zhou, Ting
    Huang, Yan
    Zhang, Li
    MEDICINE, 2015, 94 (44) : e1949
12345